A Bioequivalence study of a randomized, open-label, single dose, full replicated crossover design with four-period, two-treatment, and two-sequence of Edoxaban tablets 60 mg relative to LIXIANA tablets 60 mg in healthy Thai participants under fasting condition
A Single-dose, Randomized, Open-label, Crossover Bioequivalence Study of Generic Azilsartan Medoxomil 80 mg Tablets and Reference Product in Healthy Thai Participants under Fasting Conditions
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Lacosamide Film Coated Tablets 100 mg relative to VIMPAT Film Coated Tablets 100 mg in Thai healthy participants under fasting condition
100 项与 Bio-Innova Co. Ltd. 相关的临床结果
0 项与 Bio-Innova Co. Ltd. 相关的专利(医药)
100 项与 Bio-Innova Co. Ltd. 相关的药物交易
100 项与 Bio-Innova Co. Ltd. 相关的转化医学